Li Li

Prof. Li Li


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2021 in Science Advances
Verified
Journal Article
Open access
JCJinbo Cheng
Jinbo Cheng
渊董渊 董
渊 董
JMJun Ma
Jun Ma
RPRuiyuan Pan
Ruiyuan Pan
YLYajin Liao
Yajin Liao
ZYZengqiang Yuan
Zengqiang Yuan
Calhm2 has an important role in microglial activation and contributes to Alzheimer’s disease pathology.


3 July 2023 in Advanced Science
Verified
Journal Article
Open access
LLLi Li
Li Li
WHWenyu Hu
Wenyu Hu
SGShenghui Gong
Shenghui Gong
PZPing Zhang
Ping Zhang
JCJinbo Cheng
Jinbo Cheng
ZYZengqiang Yuan
Zengqiang Yuan
High altitude exposure leads to various cognitive impairments. The cerebral vasculature system plays an integral role in hypoxia‐induced cognitive defects by reducing oxygen and nutrition supply to the brain. RNA N6‐methyladenosine (m6A) is susceptible to modification and regulates gene expression in response to environmental changes, including hypoxia. However, the biological significance of m6A in endothelial cell performance under hypoxic conditions is unknown. Using m6A‐seq, RNA immunoprcipitation‐seq, and transcriptomic co‐analysis, the molecular mechanism of vascular system remodeling under acute hypoxia is investigated. A novel m6A reader protein, proline‐rich coiled‐coil 2B (PRRC2B), exists in endothelial cells. PRRC2B knockdown promoted hypoxia‐induced endothelial cell migration by regulating alternative splicing of the alpha 1 chain of collagen type XII in an m6A‐dependent manner and the decay of matrix metallopeptidase domain 14 and ADAM metallopeptidase domain 19 mRNA in an m6A‐independent manner. In addition, conditional knockout of PRRC2B in endothelial cells promotes hypoxia‐induced vascular remodeling and cerebral blood flow redistribution, thus alleviating hypoxia‐induced cognitive decline. Therefore, PRRC2B is integral in the hypoxia‐induced vascular remodeling process as a novel RNA‐binding protein. These findings provide a new potential therapeutic target for hypoxia‐induced cognitive decline.

1 June 2023 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
PZPing Zhang
Ping Zhang
SGShenghui Gong
Shenghui Gong
LLLi Li
Li Li
ZYZengqiang Yuan
Zengqiang Yuan

24 June 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZZZhongtao Zhou
Zhongtao Zhou
JRJiajia Ren
Jiajia Ren
Qiankun LiuQiankun Liu
Qiankun Liu
LLLi Li
Li Li
JXJiahui Xu
Jiahui Xu
JZJing Zhang
Jing Zhang
Cancer-related cognitive impairment is a significant clinical challenge observed in patients with breast cancer, manifesting during or after treatment. This impairment leads to deteriorations in memory, processing speed, attention, and executive functioning, which profoundly impact patients' occupational performance, daily living activities, and overall quality of life. Grounded in the Symptom Science Model 2.0, this study investigates the contributing factors to Cancer-related cognitive impairment in breast cancer patients and develops a predictive nomogram for this demographic. Employing both univariate and multivariate logistic regression analyses, this investigation delineates the predictive factors influencing outcomes in breast cancer patients. A nomogram was constructed leveraging these identified predictive factors, accompanied by internal validation through bootstrap resampling methodology (1000 bootstrap samples). The efficacy of the predictive model was assessed by employing the Hosmer–Lemeshow goodness-of-fit test and calibration curves. The prevalence of cognitive impairment in breast cancer patients was identified to be 45.83%.Multivariate logistic regression analysis identified the independent predictors of Cancer-related cognitive impairment in breast cancer patients as place of residence, educational level, chemotherapy, benefit finding, post-traumatic growth, anxiety, fear of cancer progression, and fasting blood glucose levels. these factors were integrated into the nomogram. The Hosmer–Lemeshow goodness-of-fit test demonstrated that the prediction model was appropriately calibrated (χ2 = 11.520, P = 0.174). Furthermore, the model exhibited an area under the curve of 0.955 (95% CI 0.939 to 0.971) and a sensitivity of 0.906, evidencing its robust discriminative capacity and accuracy. Utilizing the Symptom Science Model 2.0 as a framework, this study comprehensively examines the multifaceted factors influencing Cancer-related cognitive impairment in breast cancer patients, spanning five critical domains: complex symptoms, phenotypic characterization, biobehavioral factors, social determinants of health, and patient-centered experiences. A predictive nomogram model was established, demonstrating satisfactory predictive accuracy and capability. This model is capable of identifying breast cancer patients with cognitive impairments with high precision. The findings furnish empirical evidence in support of the early detection, diagnosis, and intervention strategies for high-risk breast cancer patients afflicted with Cancer-related cognitive impairment.

1 March 2025 in International Immunopharmacology
Verified
Journal Article
Closed access
YZYang Zhang
Yang Zhang
NCNa Che
Na Che
BWBo Wang
Bo Wang
SLShuhan Liu
Shuhan Liu
YDYuan Dong
Yuan Dong
YLYajin Liao
Yajin Liao